Insiders sold 22K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Feb 2023.
Get an email when CCCC's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jan 16 | Leonard Reyno Chief Medical Officer | SoldNo plan | 10,000 | $2.22 | 22K | 6.0% | Form 4 |
| Feb 14, 2025 – Feb 18, 2025 | Scott N Boyle Chief Business Officer | Sold10b5-1 plan 2 parts | 1,159 | $3.15 average | 4K | 1.1% | Form 4 |
- Jan 16No planLeonard ReynoChief Medical Officer · sold 10,000 at $2.2222K6.0% of stake
- Feb 14, 2025 – Feb 18, 202510b5-1 planScott N BoyleChief Business Officer · sold 1,159 at avg $3.154K1.1% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CCCC
Held by ETFs
CCCC is in 12 US ETFs. The largest of them, with CCCC's weight in each:
iShares Russell 2000 Value ETFIWN0.02%of the fund
iShares Biotechnology ETFIBB0.03%of the fund
Fidelity Enhanced Small Cap ETFFESM0.06%of the fund
Avantis U.S. Small Cap Equity ETFAVSC0.02%of the fund
Invesco RAFI US 1500 Small-Mid ETFPRFZ0.03%of the fund
Vanguard U.S. Momentum Factor ETFVFMO0.06%of the fund
Spot a number that looks wrong? Check it in CCCC's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CCCC
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.